FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320486588> ?p ?o ?g. }

• W4320486588 endingPage "206" @default.
• W4320486588 startingPage "197" @default.
• W4320486588 abstract "Tafamidis was approved for the treatment of hereditary and wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) in May 2019, based on findings from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT).This retrospective cohort study evaluated the factors associated with tafamidis prescription after diagnosis of ATTRwt-CM in the real world. Between May 2019 and December 2020, 430 patients with 6 months' database activity were indexed from the de-identified US Optum electronic healthcare records at first diagnosis of ATTRwt-CM or prescription of tafamidis, then followed until last activity or death. Of these, 209 patients were prescribed tafamidis during follow-up, 167 (80%) within 1 month, 98% by 6 months, and 100% by 9 months. Median time from index to tafamidis prescription, calculated using the Kaplan-Meier method, was 5.8 months (95% confidence interval [CI] 2.4-not evaluable).Factors associated with tafamidis prescription in a multivariable Cox proportional hazards regression (hazard ratio [95% CI]) included age ≥ 65 years (2.1 [1.07-4.05]), male sex (1.6 [1.07-2.28]), having heart failure/cardiomyopathy (2.4 [1.54-3.82]), and having had technetium-99m pyrophosphate myocardial scintigraphy (1.7 [1.28-2.28]).The clinical characteristics of patients with ATTRwt-CM who were prescribed tafamidis in the real world were broadly comparable with those who took part in ATTR-ACT. Further studies are needed to evaluate hereditary and ATTRwt-CM patient populations in the real world and assess the long-term outcomes associated with disease management pathways.ClinicalTrials.gov identifier: NCT01994889." @default.
• W4320486588 created "2023-02-14" @default.
• W4320486588 creator A5010873597 @default.
• W4320486588 creator A5028851263 @default.
• W4320486588 creator A5029389400 @default.
• W4320486588 creator A5032837530 @default.
• W4320486588 creator A5038894250 @default.
• W4320486588 creator A5040877046 @default.
• W4320486588 creator A5060412536 @default.
• W4320486588 creator A5061515030 @default.
• W4320486588 creator A5076045633 @default.
• W4320486588 creator A5085462851 @default.
• W4320486588 date "2023-02-13" @default.
• W4320486588 modified "2023-10-06" @default.
• W4320486588 title "Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States" @default.
• W4320486588 cites W1984486655 @default.
• W4320486588 cites W2076492105 @default.
• W4320486588 cites W2081338080 @default.
• W4320486588 cites W2107491044 @default.
• W4320486588 cites W2163584170 @default.
• W4320486588 cites W2418738810 @default.
• W4320486588 cites W2509971241 @default.
• W4320486588 cites W2884209421 @default.
• W4320486588 cites W2888036721 @default.
• W4320486588 cites W2915607890 @default.
• W4320486588 cites W2948364217 @default.
• W4320486588 cites W2960721446 @default.
• W4320486588 cites W2967868442 @default.
• W4320486588 cites W2970261800 @default.
• W4320486588 cites W2970575475 @default.
• W4320486588 cites W2971824914 @default.
• W4320486588 cites W3006028248 @default.
• W4320486588 cites W3014571871 @default.
• W4320486588 cites W3087792494 @default.
• W4320486588 cites W3113084460 @default.
• W4320486588 cites W3156447939 @default.
• W4320486588 cites W3163032543 @default.
• W4320486588 cites W3170918622 @default.
• W4320486588 cites W3193281130 @default.
• W4320486588 cites W3205154127 @default.
• W4320486588 cites W3205964661 @default.
• W4320486588 cites W3206727903 @default.
• W4320486588 cites W4220915471 @default.
• W4320486588 cites W4225408423 @default.
• W4320486588 doi "https://doi.org/10.1007/s40256-022-00563-4" @default.
• W4320486588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36780092" @default.
• W4320486588 hasPublicationYear "2023" @default.
• W4320486588 type Work @default.
• W4320486588 citedByCount "1" @default.
• W4320486588 countsByYear W43204865882023 @default.
• W4320486588 crossrefType "journal-article" @default.
• W4320486588 hasAuthorship W4320486588A5010873597 @default.
• W4320486588 hasAuthorship W4320486588A5028851263 @default.
• W4320486588 hasAuthorship W4320486588A5029389400 @default.
• W4320486588 hasAuthorship W4320486588A5032837530 @default.
• W4320486588 hasAuthorship W4320486588A5038894250 @default.
• W4320486588 hasAuthorship W4320486588A5040877046 @default.
• W4320486588 hasAuthorship W4320486588A5060412536 @default.
• W4320486588 hasAuthorship W4320486588A5061515030 @default.
• W4320486588 hasAuthorship W4320486588A5076045633 @default.
• W4320486588 hasAuthorship W4320486588A5085462851 @default.
• W4320486588 hasBestOaLocation W43204865881 @default.
• W4320486588 hasConcept C121157162 @default.
• W4320486588 hasConcept C126322002 @default.
• W4320486588 hasConcept C143998085 @default.
• W4320486588 hasConcept C207103383 @default.
• W4320486588 hasConcept C2426938 @default.
• W4320486588 hasConcept C2778198053 @default.
• W4320486588 hasConcept C2778797674 @default.
• W4320486588 hasConcept C44249647 @default.
• W4320486588 hasConcept C50382708 @default.
• W4320486588 hasConcept C71924100 @default.
• W4320486588 hasConcept C72563966 @default.
• W4320486588 hasConcept C98274493 @default.
• W4320486588 hasConceptScore W4320486588C121157162 @default.
• W4320486588 hasConceptScore W4320486588C126322002 @default.
• W4320486588 hasConceptScore W4320486588C143998085 @default.
• W4320486588 hasConceptScore W4320486588C207103383 @default.
• W4320486588 hasConceptScore W4320486588C2426938 @default.
• W4320486588 hasConceptScore W4320486588C2778198053 @default.
• W4320486588 hasConceptScore W4320486588C2778797674 @default.
• W4320486588 hasConceptScore W4320486588C44249647 @default.
• W4320486588 hasConceptScore W4320486588C50382708 @default.
• W4320486588 hasConceptScore W4320486588C71924100 @default.
• W4320486588 hasConceptScore W4320486588C72563966 @default.
• W4320486588 hasConceptScore W4320486588C98274493 @default.
• W4320486588 hasFunder F4320307765 @default.
• W4320486588 hasIssue "2" @default.
• W4320486588 hasLocation W43204865881 @default.
• W4320486588 hasLocation W43204865882 @default.
• W4320486588 hasLocation W43204865883 @default.
• W4320486588 hasOpenAccess W4320486588 @default.
• W4320486588 hasPrimaryLocation W43204865881 @default.
• W4320486588 hasRelatedWork W1727188710 @default.
• W4320486588 hasRelatedWork W1966656446 @default.
• W4320486588 hasRelatedWork W2088206352 @default.
• W4320486588 hasRelatedWork W2119154902 @default.
• W4320486588 hasRelatedWork W2133235702 @default.

• next